Methadone Hydrochloride Inn-Farm

Methadone Hydrochloride, the active ingredient in Methadone Hydrochloride Inn-Farm, is a synthetic opioid analgesic presented as an oral formulation for oral use. It is employed in the treatment of opioid dependence and for management of severe chronic pain in adult patients under medical supervision and requires careful dosing by qualified healthcare professionals.

GNH USA supplies Methadone Hydrochloride Inn-Farm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide with robust quality assurance and regulatory compliance across multiple regions.

Methadone Hydrochloride is used in opioid‑related disorders and chronic pain management. - Opioid dependence (maintenance therapy): reduces withdrawal symptoms and cravings, supporting long‑term abstinence. - Severe chronic pain: provides long‑acting analgesia for patients requiring opioid therapy. - Opioid detoxification: facilitates supervised withdrawal by stabilizing opioid receptors.

Methadone Hydrochloride may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to infrequent stools. - Nausea: feeling of sickness that may accompany oral intake. - Drowsiness: increased sleepiness affecting daily activities. - Sweating: excessive perspiration, especially at night.

Serious or Rare Side Effects: - Respiratory depression: slowed breathing that can be life‑threatening. - QT interval prolongation: cardiac electrical disturbance increasing arrhythmia risk. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting.

When prescribing Methadone Hydrochloride, clinicians should observe several safety measures to minimize risk. - Assess opioid tolerance: confirm the patient has prior exposure to opioids before initiating therapy. - Monitor respiratory function: observe for signs of depression, especially during dose adjustments. - Avoid use in acute severe asthma: methadone may exacerbate bronchospasm. - Use caution in hepatic impairment: liver disease can alter drug metabolism and increase plasma levels. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Methadone Hydrochloride interacts with several medications; awareness of these interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Concomitant CNS depressants: additive effect on respiratory depression and sedation. - QT‑prolonging agents: combined risk of cardiac arrhythmias. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may raise methadone plasma concentrations.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampin): can lower methadone levels and reduce efficacy. - Selective serotonin reuptake inhibitors: increase risk of serotonin syndrome when combined.